Knowledge (XXG)

Heterogeneous ribonucleoprotein particle

Source đź“ť

17: 141:, and co-regulating certain cell cycle control proteins. Much of hnRNPs' importance to cell cycle control is evidenced by its role as an oncogene, in which a loss of its functions results in various common cancers. Often, misregulation by hnRNPs is due to splicing errors, but some hnRNPs are also responsible for recruiting and guiding the proteins themselves, rather than just addressing nascent RNAs. 225:). p53 suppression of genes is often carried out by a number of these lincRNAs, which in turn have been shown to act though hnRNP K. Through physical interactions with these molecules, hnRNP K is targeted to genes and transmits p53 regulation, thus acting as a key repressor within the p53-dependent transcriptional pathway. 129:. hnRNPs are also responsible for strengthening and inhibiting splice sites by making such sites more or less accessible to the spliceosome. Cooperative interactions between attached hnRNPs may encourage certain splicing combinations while inhibiting others. 164:
progression of the cell is impaired. Additionally, BRCA1 and BRCA2 levels fall when hnRNP C is lost. BRCA1 and BRCA2 are crucial tumor-suppressor genes which are strongly implicated in breast cancers when mutated. BRCA1 in particular causes
247:
The association of a pre-mRNA molecule with a hnRNP particle prevents formation of short secondary structures dependent on base pairing of complementary regions, thereby making the pre-mRNA accessible for interactions with other proteins.
173:
signaling cascade. hnRNP C is important for the proper expression of other tumor suppressor genes including RAD51 and BRIP1 as well. Through these genes, hnRNP is necessary to induce cell-cycle arrest in response to DNA damage by
189:
is overexpressed in 20-30% of breast cancers and is commonly associated with poor prognosis. It is therefore an oncogene whose differently spliced variants have been shown to have different functions. Knocking down
50:
of the newly synthesized RNA (pre-mRNA). The presence of the proteins bound to a pre-mRNA molecule serves as a signal that the pre-mRNA is not yet fully processed and therefore not ready for export to the
299:, the protein responsible for elongating telomeres and prevent their degradation. hnRNPs C1 and C2 associate with the RNA component of telomerase, which improves its ability to access the telomere. 86:
shows nucleoplasmic localization of these proteins with little staining in the nucleolus or cytoplasm. This is likely because of its major role in binding to newly transcribed RNAs. High-resolution
214:
is rapidly induced after DNA damage by ionizing radiation. It cooperates with p53 to induce the activation of p53 target genes, thus activating cell-cycle checkpoints. p53 itself is an important
547:
Beyer, Ann L.; Christensen, Mark E.; Walker, Barbara W.; LeStourgeon, Wallace M. (1977). "Identification and characterization of the packaging proteins of core 40S hnRNP particles".
194:
was shown to increase the amount of an oncogenic variant Δ16HER2. HER2 is an upstream regulator of cyclin D1 and p27, and its overexpression leads to the deregulation of the
264:, through splicing mechanisms. CD44 is involved in cell-cell interactions and has roles in cell adhesion and migration. Splicing of CD44 and the functions of the resulting 1782: 1772: 1767: 1747: 1727: 1392:
Ford, Lance P.; Wright, Woodring E.; Shay, Jerry W. (2002-01-21). "A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation".
1123:
Huarte, Maite; Guttman, Mitchell; Feldser, David; Garber, Manuel; Koziol, Magdalena J.; Kenzelmann-Broz, Daniela; Khalil, Ahmad M.; Zuk, Or; Amit, Ido (2010).
1698: 1229:
Loh, Tiing Jen; Moon, Heegyum; Cho, Sunghee; Jang, Hana; Liu, Yong Chao; Tai, Hongmei; Jung, Da-Woon; Williams, Darren R.; Kim, Hey-Ran (September 2015).
218:
sometimes known by the epithet “the guardian of the genome.” hnRNP K’s close association with p53 demonstrates its importance in DNA damage control.
67: 1666: 796: 699: 590:
Dreyfuss, Gideon; Matunis, Michael J.; Pinol-Roma, Serafin; Burd, Christopher G. (1993-06-01). "hnRNP Proteins and the Biogenesis of mRNA".
388: 102: 828:
Anantha, Rachel W.; Alcivar, Allen L.; Ma, Jianglin; Cai, Hong; Simhadri, Srilatha; Ule, Jernej; König, Julian; Xia, Bing (2013-04-09).
1757: 1752: 78:(NLS) and are therefore found mainly in the nucleus. Though it is known that a few hnRNPs shuttle between the cytoplasm and nucleus, 59:
in the nucleus exist as heterogeneous ribonucleoprotein particles. After splicing has occurred, the proteins remain bound to spliced
1495: 715:
Matlin, Arianne J.; Clark, Francis; Smith, Christopher W. J. (2005). "Understanding alternative splicing: towards a cellular code".
47: 1691: 769:
Martinez-Contreras, Rebeca; Cloutier, Philippe; Shkreta, Lulzim; Fisette, Jean-François; Revil, Timothée; Chabot, Benoit (2007).
1174:"The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions" 960:
Gautrey, Hannah; Jackson, Claire; Dittrich, Anna-Lena; Browell, David; Lennard, Thomas; Tyson-Capper, Alison (2015-10-03).
75: 1927: 1901: 1684: 289: 98: 97:
The proteins involved in the hnRNP complexes are collectively known as heterogeneous ribonucleoproteins. They include
160:
genes. In response to ionizing radiation, hnRNP C partially localizes to the site of DNA damage, and when depleted,
1485: 237:
Preventing the folding of pre-mRNA into secondary structures that may inhibit its interactions with other proteins.
166: 635:"Ultrastructural distribution of nuclear ribonucleoproteins as visualized by immunocytochemistry on thin sections" 221:
p53 regulates a large group of RNAs that are not translated into protein, called large intergenic noncoding RNAs (
268:
are different in breast cancer cells, and when knocked down, hnRNP reduced both cell viability and invasiveness.
830:"Requirement of Heterogeneous Nuclear Ribonucleoprotein C for BRCA Gene Expression and Homologous Recombination" 1922: 43: 1614:"Specific binding of heterogeneous ribonucleoprotein particle protein K to the human c-myc promoter, in vitro" 897:"Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage" 413: 74:
and therefore important for the translation of mRNA in the cytoplasm. However, hnRNPs also have their own
1337:"Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase" 215: 1437:"The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins" 1280:"In vitro properties of the conserved mammalian protein hnRNP D suggest a role in telomere maintenance" 1231:"CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer" 1019:"The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis" 1529: 1125:"A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response" 841: 493: 138: 126: 1885: 1793: 1707: 222: 87: 56: 1518:"Protein kinase A phosphorylation modulates transport of the polypyrimidine tract-binding protein" 1105: 942: 748: 572: 175: 79: 288:
associates with the G-rich repeat region of the telomeres, possibly stabilizing the region from
690:
Matsudaira PT, Lodish HF, Berk A, Kaiser C, Krieger M, Scott MP, Bretscher A, Ploegh H (2008).
323: 319: 1875: 1711: 1662: 1645: 1600: 1557: 1491: 1466: 1458: 1417: 1409: 1374: 1356: 1317: 1299: 1260: 1252: 1211: 1193: 1154: 1097: 1056: 1038: 999: 981: 934: 916: 877: 859: 810: 802: 792: 780: 771: 740: 732: 695: 672: 654: 615: 607: 564: 529: 511: 442: 438: 434: 350: 341: 1635: 1625: 1590: 1582: 1547: 1537: 1448: 1401: 1364: 1348: 1307: 1291: 1242: 1201: 1185: 1144: 1136: 1087: 1046: 1030: 989: 973: 924: 908: 867: 849: 784: 724: 662: 646: 599: 556: 519: 501: 408: 403: 364: 110: 1676: 1076:"hnRNP K: An HDM2 Target and Transcriptional Coactivator of p53 in Response to DNA Damage" 265: 195: 106: 1533: 929: 896: 845: 603: 497: 16: 1595: 1570: 1206: 1173: 1149: 1124: 1051: 1018: 994: 961: 912: 872: 829: 667: 634: 1630: 1613: 1552: 1517: 1453: 1436: 524: 481: 1916: 1369: 1352: 1336: 1312: 1295: 1279: 1074:
Moumen, Abdeladim; Masterson, Philip; O'Connor, Mark J.; Jackson, Stephen P. (2005).
560: 459: 1109: 946: 752: 576: 261: 114: 39: 977: 1172:
Sun, Xinghui; Ali, Mohamed Sham Shihabudeen Haider; Moran, Matthew (2017-09-01).
854: 788: 122: 1140: 1092: 1075: 962:"SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells" 1849: 1586: 296: 281: 55:. Since most mature RNA is exported from the nucleus relatively quickly, most 1462: 1413: 1360: 1303: 1256: 1197: 1042: 985: 920: 863: 806: 736: 658: 611: 515: 1542: 91: 52: 1604: 1561: 1421: 1405: 1378: 1321: 1264: 1215: 1158: 1101: 1060: 1034: 1003: 938: 881: 814: 744: 506: 482:"Detection of mRNA sequences in nuclear 30S ribonucleoprotein subcomplexes" 1649: 1470: 676: 619: 533: 1865: 1247: 1230: 779:. Advances in Experimental Medicine and Biology. Vol. 623. pp.  650: 568: 331: 315: 277: 186: 83: 71: 1189: 233:
hnRNP serves a variety of processes in the cell, some of which include:
1818: 1800: 1789: 424: 336: 311: 307:
Human genes encoding heterogeneous nuclear ribonucleoproteins include:
161: 35: 1640: 90:
has shown that hnRNPs localize predominantly to the border regions of
1833: 1828: 1823: 1762: 1742: 1732: 1335:
Ford, L. P.; Suh, J. M.; Wright, W. E.; Shay, J. W. (December 2000).
419: 399: 394: 383: 379: 375: 359: 355: 346: 327: 191: 149: 60: 728: 206:
hnRNPs also play a role in DNA damage response in coordination with
1661:. San Francisco: Pearson/Benjamin Cummings. pp. ch. 9 and 10. 1777: 1737: 1719: 1571:"The hnRNP Family: Insights into Their Role in Health and Disease" 430: 285: 211: 170: 157: 153: 15: 284:
from deterioration and are often associated with cell longevity.
447: 369: 257: 207: 118: 1680: 137:
hnRNPs affect several aspects of the cell cycle by recruiting,
1612:
Takimoto M, Tomonaga T, Matunis M, et al. (August 1993).
31: 1516:
Xie J, Lee JA, Kress TL, Mowry KL, Black DL (July 2003).
462:: complex between mRNA and protein(s) present in nucleus 1484:
Dityatev, Alexander; El-Husseini, Alaa (2006-11-24).
1435:
Görlach, M.; Burd, C. G.; Dreyfuss, G. (1994-09-16).
633:
Fakan, S.; Leser, G.; Martin, T. E. (January 1984).
169:
cell cycle arrest in response to DNA damage via the
1894: 1874: 1858: 1842: 1809: 1718: 895:Yoshida, Kiyotsugu; Miki, Yoshio (November 2004). 770: 1569:Geuens T, Delphine B, Timmerman V (August 2016). 240:Possible association with the splicing apparatus. 486:Proceedings of the National Academy of Sciences 480:Kinniburgh, A. J.; Martin, T. E. (1976-08-01). 1692: 94:, where it has access to these nascent RNAs. 8: 777:Alternative Splicing in the Postgenomic Era 295:hnRNP has also been shown to interact with 1699: 1685: 1677: 292:which would inhibit telomere replication. 1639: 1629: 1594: 1551: 1541: 1452: 1368: 1311: 1278:Eversole, A.; Maizels, N. (August 2000). 1246: 1205: 1148: 1091: 1050: 993: 928: 871: 853: 666: 523: 505: 24:Heterogeneous nuclear ribonucleoproteins 472: 1487:Molecular Mechanisms of Synaptogenesis 772:"HNRNP Proteins and Splicing Control" 717:Nature Reviews Molecular Cell Biology 243:Transport of mRNA out of the nucleus. 7: 764: 762: 103:polypyrimidine tract-binding protein 1441:The Journal of Biological Chemistry 604:10.1146/annurev.bi.62.070193.001445 113:and is responsible for suppressing 913:10.1111/j.1349-7006.2004.tb02195.x 14: 256:hnRNP has been shown to regulate 133:Role in cell cycle and DNA damage 63:and target them for degradation. 48:post-transcriptional modification 1353:10.1128/mcb.20.23.9084-9091.2000 1296:10.1128/mcb.20.15.5425-5432.2000 66:hnRNPs are also integral to the 694:. San Francisco: W.H. Freeman. 1341:Molecular and Cellular Biology 1284:Molecular and Cellular Biology 76:nuclear localization sequences 1: 1659:Molecular biology of the gene 1631:10.1016/S0021-9258(17)46837-2 1454:10.1016/S0021-9258(17)31621-6 978:10.1080/15476286.2015.1076610 592:Annual Review of Biochemistry 276:Several hnRNPs interact with 105:(PTB), which is regulated by 80:immunofluorescence microscopy 1522:Proc. Natl. Acad. Sci. U.S.A 855:10.1371/journal.pone.0061368 561:10.1016/0092-8674(77)90323-3 280:, which protect the ends of 1902:Signal recognition particle 789:10.1007/978-0-387-77374-2_8 639:The Journal of Cell Biology 1944: 1141:10.1016/j.cell.2010.06.040 1093:10.1016/j.cell.2005.09.032 152:is a key regulator of the 121:by blocking access of the 1657:Watson, James D. (2004). 1587:10.1007/s00439-016-1683-5 88:immunoelectron microscopy 1876:Vault ribonucleoprotein 1543:10.1073/pnas.1432696100 1406:10.1038/sj.onc.1205086 1035:10.1038/sj.onc.1210477 692:Molecular cell biology 507:10.1073/pnas.73.8.2725 20: 1017:Moasser, M M (2007). 216:tumor-suppressor gene 19: 1248:10.3892/or.2015.4110 651:10.1083/jcb.98.1.358 290:secondary structures 127:polypyrimidine tract 82:with hnRNP-specific 1886:Major vault protein 1843:Other transcription 1794:U1 spliceosomal RNA 1708:RNA-binding protein 1534:2003PNAS..100.8776X 1447:(37): 23074–23078. 1190:10.1042/bcj20170280 1178:Biochemical Journal 846:2013PLoSO...861368A 498:1976PNAS...73.2725K 57:RNA-binding protein 30:) are complexes of 1928:Ribonucleoproteins 1712:Ribonucleoproteins 176:ionizing radiation 44:gene transcription 21: 1910: 1909: 1668:978-0-8053-4635-0 1347:(23): 9084–9091. 1290:(15): 5425–5432. 1184:(17): 2925–2935. 1029:(45): 6469–6487. 972:(10): 1139–1151. 798:978-0-387-77373-5 701:978-0-7167-7601-7 260:, a cell-surface 1935: 1701: 1694: 1687: 1678: 1672: 1653: 1643: 1633: 1624:(24): 18249–58. 1608: 1598: 1565: 1555: 1545: 1502: 1501: 1481: 1475: 1474: 1456: 1432: 1426: 1425: 1389: 1383: 1382: 1372: 1332: 1326: 1325: 1315: 1275: 1269: 1268: 1250: 1241:(3): 1231–1238. 1235:Oncology Reports 1226: 1220: 1219: 1209: 1169: 1163: 1162: 1152: 1120: 1114: 1113: 1095: 1086:(6): 1065–1078. 1071: 1065: 1064: 1054: 1014: 1008: 1007: 997: 957: 951: 950: 932: 892: 886: 885: 875: 857: 825: 819: 818: 774: 766: 757: 756: 712: 706: 705: 687: 681: 680: 670: 630: 624: 623: 587: 581: 580: 544: 538: 537: 527: 509: 492:(8): 2725–2729. 477: 117:at a particular 111:protein kinase A 1943: 1942: 1938: 1937: 1936: 1934: 1933: 1932: 1923:Gene expression 1913: 1912: 1911: 1906: 1890: 1877: 1870: 1854: 1838: 1805: 1714: 1705: 1675: 1669: 1656: 1611: 1568: 1528:(15): 8776–81. 1515: 1511: 1509:Further reading 1506: 1505: 1498: 1483: 1482: 1478: 1434: 1433: 1429: 1391: 1390: 1386: 1334: 1333: 1329: 1277: 1276: 1272: 1228: 1227: 1223: 1171: 1170: 1166: 1122: 1121: 1117: 1073: 1072: 1068: 1016: 1015: 1011: 959: 958: 954: 907:(11): 866–871. 894: 893: 889: 827: 826: 822: 799: 768: 767: 760: 729:10.1038/nrm1645 714: 713: 709: 702: 689: 688: 684: 632: 631: 627: 589: 588: 584: 546: 545: 541: 479: 478: 474: 469: 456: 305: 274: 254: 252:CD44 Regulation 231: 204: 184: 147: 135: 107:phosphorylation 70:subunit of the 46:and subsequent 38:present in the 12: 11: 5: 1941: 1939: 1931: 1930: 1925: 1915: 1914: 1908: 1907: 1905: 1904: 1898: 1896: 1892: 1891: 1889: 1888: 1882: 1880: 1872: 1871: 1869: 1868: 1862: 1860: 1856: 1855: 1853: 1852: 1846: 1844: 1840: 1839: 1837: 1836: 1831: 1826: 1821: 1815: 1813: 1807: 1806: 1804: 1803: 1797: 1796: 1786: 1785: 1780: 1775: 1770: 1765: 1760: 1755: 1750: 1745: 1740: 1735: 1730: 1724: 1722: 1716: 1715: 1706: 1704: 1703: 1696: 1689: 1681: 1674: 1673: 1667: 1654: 1609: 1575:Human Genetics 1566: 1512: 1510: 1507: 1504: 1503: 1496: 1476: 1427: 1400:(4): 580–583. 1384: 1327: 1270: 1221: 1164: 1135:(3): 409–419. 1115: 1066: 1009: 952: 901:Cancer Science 887: 820: 797: 758: 723:(5): 386–398. 707: 700: 682: 645:(1): 358–363. 625: 598:(1): 289–321. 582: 555:(1): 127–138. 539: 471: 470: 468: 465: 464: 463: 455: 452: 451: 450: 445: 428: 422: 417: 411: 406: 397: 392: 386: 373: 367: 362: 353: 344: 339: 334: 304: 301: 273: 270: 253: 250: 245: 244: 241: 238: 230: 227: 203: 200: 183: 180: 146: 143: 134: 131: 13: 10: 9: 6: 4: 3: 2: 1940: 1929: 1926: 1924: 1921: 1920: 1918: 1903: 1900: 1899: 1897: 1893: 1887: 1884: 1883: 1881: 1879: 1873: 1867: 1864: 1863: 1861: 1857: 1851: 1848: 1847: 1845: 1841: 1835: 1832: 1830: 1827: 1825: 1822: 1820: 1817: 1816: 1814: 1812: 1808: 1802: 1799: 1798: 1795: 1791: 1788: 1787: 1784: 1781: 1779: 1776: 1774: 1771: 1769: 1766: 1764: 1761: 1759: 1756: 1754: 1751: 1749: 1746: 1744: 1741: 1739: 1736: 1734: 1731: 1729: 1726: 1725: 1723: 1721: 1717: 1713: 1709: 1702: 1697: 1695: 1690: 1688: 1683: 1682: 1679: 1670: 1664: 1660: 1655: 1651: 1647: 1642: 1637: 1632: 1627: 1623: 1619: 1618:J. Biol. Chem 1615: 1610: 1606: 1602: 1597: 1592: 1588: 1584: 1581:(8): 851–67. 1580: 1576: 1572: 1567: 1563: 1559: 1554: 1549: 1544: 1539: 1535: 1531: 1527: 1523: 1519: 1514: 1513: 1508: 1499: 1497:9780387325620 1493: 1489: 1488: 1480: 1477: 1472: 1468: 1464: 1460: 1455: 1450: 1446: 1442: 1438: 1431: 1428: 1423: 1419: 1415: 1411: 1407: 1403: 1399: 1395: 1388: 1385: 1380: 1376: 1371: 1366: 1362: 1358: 1354: 1350: 1346: 1342: 1338: 1331: 1328: 1323: 1319: 1314: 1309: 1305: 1301: 1297: 1293: 1289: 1285: 1281: 1274: 1271: 1266: 1262: 1258: 1254: 1249: 1244: 1240: 1236: 1232: 1225: 1222: 1217: 1213: 1208: 1203: 1199: 1195: 1191: 1187: 1183: 1179: 1175: 1168: 1165: 1160: 1156: 1151: 1146: 1142: 1138: 1134: 1130: 1126: 1119: 1116: 1111: 1107: 1103: 1099: 1094: 1089: 1085: 1081: 1077: 1070: 1067: 1062: 1058: 1053: 1048: 1044: 1040: 1036: 1032: 1028: 1024: 1020: 1013: 1010: 1005: 1001: 996: 991: 987: 983: 979: 975: 971: 967: 963: 956: 953: 948: 944: 940: 936: 931: 926: 922: 918: 914: 910: 906: 902: 898: 891: 888: 883: 879: 874: 869: 865: 861: 856: 851: 847: 843: 840:(4): e61368. 839: 835: 831: 824: 821: 816: 812: 808: 804: 800: 794: 790: 786: 782: 778: 773: 765: 763: 759: 754: 750: 746: 742: 738: 734: 730: 726: 722: 718: 711: 708: 703: 697: 693: 686: 683: 678: 674: 669: 664: 660: 656: 652: 648: 644: 640: 636: 629: 626: 621: 617: 613: 609: 605: 601: 597: 593: 586: 583: 578: 574: 570: 566: 562: 558: 554: 550: 543: 540: 535: 531: 526: 521: 517: 513: 508: 503: 499: 495: 491: 487: 483: 476: 473: 466: 461: 460:Messenger RNP 458: 457: 453: 449: 446: 444: 440: 436: 432: 429: 426: 423: 421: 418: 415: 412: 410: 407: 405: 401: 398: 396: 393: 390: 387: 385: 381: 377: 374: 371: 368: 366: 363: 361: 357: 354: 352: 348: 345: 343: 340: 338: 335: 333: 329: 325: 321: 317: 313: 310: 309: 308: 302: 300: 298: 293: 291: 287: 283: 279: 271: 269: 267: 263: 259: 251: 249: 242: 239: 236: 235: 234: 228: 226: 224: 219: 217: 213: 209: 201: 199: 197: 193: 188: 181: 179: 177: 172: 168: 163: 159: 155: 151: 144: 142: 140: 132: 130: 128: 124: 120: 116: 112: 109:catalyzed by 108: 104: 100: 95: 93: 89: 85: 81: 77: 73: 69: 64: 62: 58: 54: 49: 45: 41: 37: 33: 29: 25: 18: 1810: 1658: 1621: 1617: 1578: 1574: 1525: 1521: 1490:. Springer. 1486: 1479: 1444: 1440: 1430: 1397: 1393: 1387: 1344: 1340: 1330: 1287: 1283: 1273: 1238: 1234: 1224: 1181: 1177: 1167: 1132: 1128: 1118: 1083: 1079: 1069: 1026: 1022: 1012: 969: 965: 955: 904: 900: 890: 837: 833: 823: 776: 720: 716: 710: 691: 685: 642: 638: 628: 595: 591: 585: 552: 548: 542: 489: 485: 475: 306: 294: 275: 262:glycoprotein 255: 246: 232: 220: 205: 198:checkpoint. 185: 148: 136: 115:RNA splicing 96: 65: 40:cell nucleus 27: 23: 22: 1859:Translation 966:RNA Biology 282:chromosomes 123:spliceosome 1917:Categories 1850:Telomerase 1641:2115/72478 467:References 297:telomerase 84:antibodies 1878:particles 1463:0021-9258 1414:0950-9232 1361:0270-7306 1304:0270-7306 1257:1791-2431 1198:0264-6021 1043:1476-5594 986:1547-6286 921:1347-9032 864:1932-6203 807:0065-2598 737:1471-0080 659:0021-9525 612:0066-4154 516:0027-8424 427:(SYNCRIP) 416:(FUS/TLS) 332:HNRNPA2B1 324:HNRNPA1L2 320:HNRNPA1L1 278:telomeres 272:Telomeres 229:Functions 99:protein K 92:chromatin 53:cytoplasm 1866:Ribosome 1801:SNRNP200 1605:27215579 1562:12851456 1422:11850782 1394:Oncogene 1379:11074006 1322:10891483 1265:26151392 1216:28801479 1159:20673990 1110:16756766 1102:16360036 1061:17471238 1023:Oncogene 1004:26367347 947:24297965 939:15546503 930:11159131 882:23585894 834:PLOS ONE 815:18380344 753:14883495 745:15956978 577:41245800 454:See also 443:HNRNPUL3 439:HNRNPUL2 435:HNRNPUL1 358:(AUF1), 351:HNRNPCL1 303:Examples 266:isoforms 223:lincRNAs 192:hnRNP H1 139:splicing 72:ribosome 1650:8349701 1596:4947485 1530:Bibcode 1471:8083209 1207:5553131 1150:2956184 1052:3021475 995:4829299 873:3621867 842:Bibcode 781:123–147 677:6231300 668:2113018 620:8352591 534:1066686 494:Bibcode 414:HNRNPP2 384:HNRNPH3 380:HNRNPH2 376:HNRNPH1 342:HNRNPB1 337:HNRNPAB 328:HNRNPA3 316:HNRNPA1 312:HNRNPA0 286:hnRNP D 212:hnRNP K 162:S-phase 150:hnRNP C 125:to the 61:introns 42:during 36:protein 1665:  1648:  1603:  1593:  1560:  1553:166389 1550:  1494:  1469:  1461:  1420:  1412:  1377:  1367:  1359:  1320:  1310:  1302:  1263:  1255:  1214:  1204:  1196:  1157:  1147:  1108:  1100:  1059:  1049:  1041:  1002:  992:  984:  945:  937:  927:  919:  880:  870:  862:  813:  805:  795:  751:  743:  735:  698:  675:  665:  657:  618:  610:  575:  569:872217 567:  532:  525:430721 522:  514:  431:HNRNPU 425:HNRNPQ 420:HNRNPR 409:HNRNPM 404:HNRPLL 400:HNRNPL 395:HNRNPK 389:HNRNPI 372:(RBMX) 370:HNRNPG 365:HNRNPF 360:HNRPDL 356:HNRNPD 347:HNRNPC 28:hnRNPs 1895:Other 1811:hnRNP 1720:snRNP 1370:86561 1313:85994 1106:S2CID 943:S2CID 749:S2CID 573:S2CID 391:(PTB) 171:CHEK1 158:BRCA2 154:BRCA1 145:BRCA1 1663:ISBN 1646:PMID 1601:PMID 1558:PMID 1492:ISBN 1467:PMID 1459:ISSN 1418:PMID 1410:ISSN 1375:PMID 1357:ISSN 1318:PMID 1300:ISSN 1261:PMID 1253:ISSN 1212:PMID 1194:ISSN 1155:PMID 1129:Cell 1098:PMID 1080:Cell 1057:PMID 1039:ISSN 1000:PMID 982:ISSN 935:PMID 917:ISSN 878:PMID 860:ISSN 811:PMID 803:ISSN 793:ISBN 741:PMID 733:ISSN 696:ISBN 673:PMID 655:ISSN 616:PMID 608:ISSN 565:PMID 549:Cell 530:PMID 512:ISSN 448:FMR1 258:CD44 196:G1/S 187:HER2 182:HER2 167:G2/M 156:and 119:exon 101:and 34:and 1790:70K 1636:hdl 1626:doi 1622:268 1591:PMC 1583:doi 1579:135 1548:PMC 1538:doi 1526:100 1449:doi 1445:269 1402:doi 1365:PMC 1349:doi 1308:PMC 1292:doi 1243:doi 1202:PMC 1186:doi 1182:474 1145:PMC 1137:doi 1133:142 1088:doi 1084:123 1047:PMC 1031:doi 990:PMC 974:doi 925:PMC 909:doi 868:PMC 850:doi 785:doi 725:doi 663:PMC 647:doi 600:doi 557:doi 520:PMC 502:doi 208:p53 202:p53 68:40S 32:RNA 1919:: 1819:A0 1763:D3 1758:D2 1753:D1 1743:B2 1733:A1 1710:: 1644:. 1634:. 1620:. 1616:. 1599:. 1589:. 1577:. 1573:. 1556:. 1546:. 1536:. 1524:. 1520:. 1465:. 1457:. 1443:. 1439:. 1416:. 1408:. 1398:21 1396:. 1373:. 1363:. 1355:. 1345:20 1343:. 1339:. 1316:. 1306:. 1298:. 1288:20 1286:. 1282:. 1259:. 1251:. 1239:34 1237:. 1233:. 1210:. 1200:. 1192:. 1180:. 1176:. 1153:. 1143:. 1131:. 1127:. 1104:. 1096:. 1082:. 1078:. 1055:. 1045:. 1037:. 1027:26 1025:. 1021:. 998:. 988:. 980:. 970:12 968:. 964:. 941:. 933:. 923:. 915:. 905:95 903:. 899:. 876:. 866:. 858:. 848:. 836:. 832:. 809:. 801:. 791:. 783:. 775:. 761:^ 747:. 739:. 731:. 719:. 671:. 661:. 653:. 643:98 641:. 637:. 614:. 606:. 596:62 594:. 571:. 563:. 553:11 551:. 528:. 518:. 510:. 500:. 490:73 488:. 484:. 441:, 437:, 433:, 402:, 382:, 378:, 349:, 330:, 326:, 322:, 318:, 314:, 210:. 178:. 1834:R 1829:L 1824:C 1792:/ 1783:N 1778:G 1773:F 1768:E 1748:C 1738:B 1728:A 1700:e 1693:t 1686:v 1671:. 1652:. 1638:: 1628:: 1607:. 1585:: 1564:. 1540:: 1532:: 1500:. 1473:. 1451:: 1424:. 1404:: 1381:. 1351:: 1324:. 1294:: 1267:. 1245:: 1218:. 1188:: 1161:. 1139:: 1112:. 1090:: 1063:. 1033:: 1006:. 976:: 949:. 911:: 884:. 852:: 844:: 838:8 817:. 787:: 755:. 727:: 721:6 704:. 679:. 649:: 622:. 602:: 579:. 559:: 536:. 504:: 496:: 26:(

Index


RNA
protein
cell nucleus
gene transcription
post-transcriptional modification
cytoplasm
RNA-binding protein
introns
40S
ribosome
nuclear localization sequences
immunofluorescence microscopy
antibodies
immunoelectron microscopy
chromatin
protein K
polypyrimidine tract-binding protein
phosphorylation
protein kinase A
RNA splicing
exon
spliceosome
polypyrimidine tract
splicing
hnRNP C
BRCA1
BRCA2
S-phase
G2/M

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑